search
Back to results

Efficacy of Early Inspiratory Muscle Training in Lung Transplanted Patients

Primary Purpose

Lung Transplant Recipients, Muscle Weakness, Respiratory Insufficiency

Status
Recruiting
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Threshold load device
Sponsored by
Puerta de Hierro University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Lung Transplant Recipients focused on measuring respiratory muscle training, post lung transplant, breathing exercises, respiratory exercises, pulmonary rehabilitation, exercise capacity

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Alert or able to cooperate with treatment.
  • Able to give Informed Consent and sign it.
  • Haemodynamically stable clinical situation or requiring minimal ventilatory support.

Exclusion Criteria:

  • Detection of complete paralysis of the diaphragm.
  • Progressive neuromuscular diseases or with spinal cord injury.
  • Lack of collaboration or cooperation, or non-alertness (Glasgow ≤8).
  • Unstable clinical situation (patients requiring high levels of ventilatory support (e.g., Positive End Expiratory Pressure (PEEP)> 10 cmH2O, Fraction Pressure of Inspired Oxygen (FiO2)> 0.60, nitric oxide, nebulised prostacyclin, high frequency oscillation).
  • Clinical situation compromising the patient's recovery (cardiac arrhythmias, acute sepsis).
  • When the medical treatment team and/or physiotherapy consider that there may be risks.
  • Severe pain or dyspnoea that interferes with or impedes the ability to breathe (e.g. rib fracture).
  • Patients with lung retransplantation.
  • Heart and lung transplant patients.
  • When the patient is on palliative treatment

Sites / Locations

  • Laura Muelas GómezRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control group: Conventional Rehabilitation Program

Experimental group: Conventional Rehabilitation Program + Inspiratory Muscle Training (IMT)

Arm Description

Standard rehabilitation program for 3 months, starting in the early phase in the ICU. A daily session from monday to friday. It includes breathing and secretions management exercises, building upper and lower extremity range of motion. Exercise progression should gradually incorporate aerobic exercises (treadmill, cycloergometer and upper and lower limb strength exercises) and limb strength training. Aerobic exercise at moderate intensity (no more than 3-4/10 on the modified Borg scale). Aerobic exercise starting with 20 minutes and gradually increasing up to 30 minutes. Limb strength training from 1 to 3 sets of 8-10 repetitions at moderate intensity.

Standard rehabilitation program for 3 months, starting in the early phase in the ICU. A daily session from monday to friday. It includes breathing and secretions management exercises, building upper and lower extremity range of motion. Exercise progression should gradually incorporate aerobic exercises (treadmill, cycloergometer and upper and lower limb strength exercises) and limb strength training. Aerobic exercise at moderate intensity (no more than 3-4/10 on the modified Borg scale). Aerobic exercise starting with 20 minutes and gradually increasing up to 30 minutes. Limb strength training from 1 to 3 sets of 8-10 repetitions at moderate intensity.

Outcomes

Primary Outcome Measures

Change in respiratory strength: maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) measured in water centimeters (cmH2O).
Maximum respiratory pressure will be measure using a Respiratory Pressure Meter (RPM) named Micro-RPM® . Ever since Black and Hyatt (1969) reported this technique, it is used in healthy control subjects across all ages and athletes. Pressure is recorded at the mouth during quasi-static short (few seconds) maximal breathing according to American Thoracic Society (ATS) guidelines.The maximum value will be obtained. Am J respi Crit Care Med 2002;166:531-535.
Change in functional capacity: 6 minutes walk test (6MWT) measured in meters
6MWT is a submaximal exercise test that entails measurement of distance walked during 6 minutes. The 6MWT provides information regarding functional capacity, response to therapy and prognosis. The test will be in line with American Thoracic Society (ATS) guidelines Statement Guidelines for the Six Minutes Walk Test. Am J respi Crit Care Med 2002;166(1):111-117
Change in Quality of life related with Health(SF-36) measured with a score from 0 to100
The SF-36 consists of 36 topics that explore eight dimensions of health status: physical function, physical role, bodily pain, general health, vitality, social function, emotional role, and mental health.The SF-36 was previously validated in chronic obstructive pulmonary disease (COPD) patients and has been used in patients before and after lung transplantation (LT). Respiration 2000;67:159-65. Chest 2000;118:408-16.
Change in Respiratory mechanics parameters: respiratory work measured in Joules (J)
Respiratory mechanics parameters will be analyzed using a POWERbreathe electronic device: the work of breathing is the area for total external inspiratory work as integrated from mouth pressure (cmH2O) and volume (L) signals over time. Physical Therapy 2015;95(9):1264-1273
Change in Inspiratory muscle endurance (Tlim) measure in seconds (s)
Inspiratory muscle endurance is the time the patient breathe against a submaximal inspiratory load provided by device (POWERbreathe) until task failure due to the symptom limitation. Physical Therapy 2015;95(9):1264-1273.

Secondary Outcome Measures

Changes in dyspnea measured with the modified borg scale 0-10
Dyspnea perceptions during the activities of daily living and during exert were assessed. Med Sci Sports Exert 1982; 14: 377-81.
Incidence of atelectasis measured with a score from 0 to 4
Registry of Atelectasis is a complete or partial collapse of the whole lung or a part (lobe) of the lung diagnosed by the responsible physician by Chest x-ray report or physician documentation of atelectasis.The postoperative chest radiographs were scored according the following rating (2): 0, no abnormalities; 1, minor atelectasis on one side; 2,minor atelectasis on both sides; 3,major atelectasis on one side; and 4, major atelectasis on both sides. Crit Care Med 2000;28:679-83. Physiotherapy 2011;97(4):278-283
Change in Pulmonary Function measured with Spirometry Test. FEV1/FVC measured in %
the investigators will interpret the data obtained from forced spirometry to evaluate how our patient's pulmonary functions is developing after the surgery. FEV1/FVC: It represents the proportion of a person's vital capacity that they are able to expire in the first second of forced expiration (FEV1) to the full, forced vital capacity (FVC).The result of this ratio is expressed as FEV1%. Spirometry is traditionally and widely used to measure pulmonary function and capacity. This test will be performed with a spirometer according to American Thoracic Society (ATS) guidelines and measured in liters . Am J respi Crit Care Med 2002;166:521-522, Eur respi J 2005; 26: 153-161.

Full Information

First Posted
February 16, 2022
Last Updated
December 15, 2022
Sponsor
Puerta de Hierro University Hospital
Collaborators
Universidad Complutense de Madrid
search

1. Study Identification

Unique Protocol Identification Number
NCT05271019
Brief Title
Efficacy of Early Inspiratory Muscle Training in Lung Transplanted Patients
Official Title
Efficacy of Early Inspiratory Muscle Training Combined With the Conventional Rehabilitation Programme in Lung Transplanted Patients
Study Type
Interventional

2. Study Status

Record Verification Date
December 2022
Overall Recruitment Status
Recruiting
Study Start Date
February 4, 2022 (Actual)
Primary Completion Date
August 15, 2024 (Anticipated)
Study Completion Date
December 30, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Puerta de Hierro University Hospital
Collaborators
Universidad Complutense de Madrid

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Lung transplantation is an effective therapeutic option in the end-stage of chronic respiratory diseases. Lung transplantation improves lung function in terms of capacity and volume. However, the transplanted patient still suffers from muscle weakness and exercise intolerance. In recent years, respiratory physiotherapy work has intensified in critically ill patients with respiratory muscle weakness and the application of inspiratory muscle training (IMT), which has been shown in several studies to increase inspiratory muscle strength (IMT), improve ventilation and reduce the sensation of shortness of breath. Despite this emerging evidence, inspiratory muscle training (IMT) is not standard practice in most ICUs around the world, nor is it included in a protocolised manner among the components of a pulmonary rehabilitation programme. Given the limited evidence, the investigators propose to conduct this randomised controlled clinical trial in lung transplant recipients. The study will compare two groups of transplanted patients, a control group that will follow the rehabilitation programme and standard medical care and another experimental group that will also perform inspiratory muscle training. This study aims to analyse the effect of IMT on inspiratory muscle strength, exercise capacity and quality of life in lung transplant patients.
Detailed Description
For many years, lung transplantation has become an effective therapeutic option for end-stage chronic lung diseases. With transplantation, an improvement in lung function is achieved, achieving volumes and capacities close to those predicted. After transplantation, muscle deterioration and exercise intolerance are still present; and it will take, according to studies, between 6 months to 1 year to achieve recovery to near normal values. Even in some cases, such as patients with a longer stay in the critical care unit who present a greater deterioration, these values do not reach normal values. In lung transplant recipients, pulmonary rehabilitation including aerobic exercise, resistance exercise and respiratory physiotherapy is the most effective strategy to improve exercise capacity and muscle strength. Some clinical trials on inspiratory muscle training have identified favourable effects on respiratory muscle fitness and strength. The purpose of this study is to analyse the impact of early training in lung transplant patients on respiratory muscle strength, exercise tolerance and quality of life. To this end, a randomised controlled trial will be carried out including lung transplant patients (single or double lung adults over 18 years of age) admitted to the hospital where a control group will perform the standard rehabilitation programme: respiratory, aerobic and upper and lower limb strength exercises; while the experimental group will be given inspiratory muscle training with a load of at least 30% of the maximum inspiratory pressure (MIP) in an early manner. Both groups will start the treatment in the critical care unit under conditions of clinical stability (haemodynamic, respiratory and neurologic) and will continue it in hospitalisation. Treatment is performed once a day, 5 days a week from Monday to Friday supervised by a trained physiotherapist. Every 15 days a data collection will be performed to monitor the follow-up and the data collection will end 3 months after the lung transplantation. The data collected will be compared from the start of treatment (pre- and post-transplant measurements) and will be compared between the groups.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lung Transplant Recipients, Muscle Weakness, Respiratory Insufficiency, Pulmonary Rehabilitation, Chronic Lung Disease
Keywords
respiratory muscle training, post lung transplant, breathing exercises, respiratory exercises, pulmonary rehabilitation, exercise capacity

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Parallel assignment
Masking
InvestigatorOutcomes Assessor
Masking Description
Neither the professionals in charge of measuring the pre- and post-intervention outcomes nor the statistician are aware of the assignment.
Allocation
Randomized
Enrollment
54 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control group: Conventional Rehabilitation Program
Arm Type
No Intervention
Arm Description
Standard rehabilitation program for 3 months, starting in the early phase in the ICU. A daily session from monday to friday. It includes breathing and secretions management exercises, building upper and lower extremity range of motion. Exercise progression should gradually incorporate aerobic exercises (treadmill, cycloergometer and upper and lower limb strength exercises) and limb strength training. Aerobic exercise at moderate intensity (no more than 3-4/10 on the modified Borg scale). Aerobic exercise starting with 20 minutes and gradually increasing up to 30 minutes. Limb strength training from 1 to 3 sets of 8-10 repetitions at moderate intensity.
Arm Title
Experimental group: Conventional Rehabilitation Program + Inspiratory Muscle Training (IMT)
Arm Type
Experimental
Arm Description
Standard rehabilitation program for 3 months, starting in the early phase in the ICU. A daily session from monday to friday. It includes breathing and secretions management exercises, building upper and lower extremity range of motion. Exercise progression should gradually incorporate aerobic exercises (treadmill, cycloergometer and upper and lower limb strength exercises) and limb strength training. Aerobic exercise at moderate intensity (no more than 3-4/10 on the modified Borg scale). Aerobic exercise starting with 20 minutes and gradually increasing up to 30 minutes. Limb strength training from 1 to 3 sets of 8-10 repetitions at moderate intensity.
Intervention Type
Device
Intervention Name(s)
Threshold load device
Intervention Description
Inspiratory Muscle Training (IMT) for 3 months: Though a threshold loading device (5 sets of 6 repetitions, 1session/day, 5 days/week). the inspiratory load will start at 30% of MIP, or up to the maximum patient-tolerable load (max 60% of MIP), no more than 3-5/10 on the modified Borg scale.
Primary Outcome Measure Information:
Title
Change in respiratory strength: maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) measured in water centimeters (cmH2O).
Description
Maximum respiratory pressure will be measure using a Respiratory Pressure Meter (RPM) named Micro-RPM® . Ever since Black and Hyatt (1969) reported this technique, it is used in healthy control subjects across all ages and athletes. Pressure is recorded at the mouth during quasi-static short (few seconds) maximal breathing according to American Thoracic Society (ATS) guidelines.The maximum value will be obtained. Am J respi Crit Care Med 2002;166:531-535.
Time Frame
The groups will be assessed at six times:Pre -Lung transplantation (Pre-LT), at baseline, every 15 days and 3 months after LT
Title
Change in functional capacity: 6 minutes walk test (6MWT) measured in meters
Description
6MWT is a submaximal exercise test that entails measurement of distance walked during 6 minutes. The 6MWT provides information regarding functional capacity, response to therapy and prognosis. The test will be in line with American Thoracic Society (ATS) guidelines Statement Guidelines for the Six Minutes Walk Test. Am J respi Crit Care Med 2002;166(1):111-117
Time Frame
The groups will be assessed Pre-LT and 3 months after LT
Title
Change in Quality of life related with Health(SF-36) measured with a score from 0 to100
Description
The SF-36 consists of 36 topics that explore eight dimensions of health status: physical function, physical role, bodily pain, general health, vitality, social function, emotional role, and mental health.The SF-36 was previously validated in chronic obstructive pulmonary disease (COPD) patients and has been used in patients before and after lung transplantation (LT). Respiration 2000;67:159-65. Chest 2000;118:408-16.
Time Frame
The groups will be assessed Pre-LT and 3 months after LT
Title
Change in Respiratory mechanics parameters: respiratory work measured in Joules (J)
Description
Respiratory mechanics parameters will be analyzed using a POWERbreathe electronic device: the work of breathing is the area for total external inspiratory work as integrated from mouth pressure (cmH2O) and volume (L) signals over time. Physical Therapy 2015;95(9):1264-1273
Time Frame
The groups will be assessed at baseline, every 15 days and 3 months after LT
Title
Change in Inspiratory muscle endurance (Tlim) measure in seconds (s)
Description
Inspiratory muscle endurance is the time the patient breathe against a submaximal inspiratory load provided by device (POWERbreathe) until task failure due to the symptom limitation. Physical Therapy 2015;95(9):1264-1273.
Time Frame
The groups will be assessed at baseline, every 15 days and 3 months after LT
Secondary Outcome Measure Information:
Title
Changes in dyspnea measured with the modified borg scale 0-10
Description
Dyspnea perceptions during the activities of daily living and during exert were assessed. Med Sci Sports Exert 1982; 14: 377-81.
Time Frame
The groups will be assessed at baseline, every 15 days and 3 months after LT
Title
Incidence of atelectasis measured with a score from 0 to 4
Description
Registry of Atelectasis is a complete or partial collapse of the whole lung or a part (lobe) of the lung diagnosed by the responsible physician by Chest x-ray report or physician documentation of atelectasis.The postoperative chest radiographs were scored according the following rating (2): 0, no abnormalities; 1, minor atelectasis on one side; 2,minor atelectasis on both sides; 3,major atelectasis on one side; and 4, major atelectasis on both sides. Crit Care Med 2000;28:679-83. Physiotherapy 2011;97(4):278-283
Time Frame
The patients will be assessed through study completion, an average of 3 months
Title
Change in Pulmonary Function measured with Spirometry Test. FEV1/FVC measured in %
Description
the investigators will interpret the data obtained from forced spirometry to evaluate how our patient's pulmonary functions is developing after the surgery. FEV1/FVC: It represents the proportion of a person's vital capacity that they are able to expire in the first second of forced expiration (FEV1) to the full, forced vital capacity (FVC).The result of this ratio is expressed as FEV1%. Spirometry is traditionally and widely used to measure pulmonary function and capacity. This test will be performed with a spirometer according to American Thoracic Society (ATS) guidelines and measured in liters . Am J respi Crit Care Med 2002;166:521-522, Eur respi J 2005; 26: 153-161.
Time Frame
The groups will be assessed Pre-LT, at baseline and 3 months after LT

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Alert or able to cooperate with treatment. Able to give Informed Consent and sign it. Haemodynamically stable clinical situation or requiring minimal ventilatory support. Exclusion Criteria: Detection of complete paralysis of the diaphragm. Progressive neuromuscular diseases or with spinal cord injury. Lack of collaboration or cooperation, or non-alertness (Glasgow ≤8). Unstable clinical situation (patients requiring high levels of ventilatory support (e.g., Positive End Expiratory Pressure (PEEP)> 10 cmH2O, Fraction Pressure of Inspired Oxygen (FiO2)> 0.60, nitric oxide, nebulised prostacyclin, high frequency oscillation). Clinical situation compromising the patient's recovery (cardiac arrhythmias, acute sepsis). When the medical treatment team and/or physiotherapy consider that there may be risks. Severe pain or dyspnoea that interferes with or impedes the ability to breathe (e.g. rib fracture). Patients with lung retransplantation. Heart and lung transplant patients. When the patient is on palliative treatment
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Laura Muelas Gómez, PT, MSc
Phone
+0034 656605303
Email
laura.muelas@salud.madrid.org
First Name & Middle Initial & Last Name or Official Title & Degree
Montserrat Solis Muñoz, PhD
Phone
+0034 911917457
Email
montserrat.solis@salud.madrid.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Laura Muelas Gómez, PT, MSc
Organizational Affiliation
Hospital Universitario Puerta de Hierro Majadahonda
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Maria de los Angeles Atín Arratibel, MD, PhD
Organizational Affiliation
Universidad Complutense de Madrid
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Maria A Cebria i Iranzo, PT, PhD
Organizational Affiliation
Hospital Universitario y Politécnico La Fe,Valencia
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Ignacio Latorre-Marco, DUE
Organizational Affiliation
Hospital Universitario Puerta de Hierro Majadahonda
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Montserrat Solis Muñoz, DUE, PhD
Organizational Affiliation
Hospital Universitario Puerta de Hierro Majadahonda
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Ana Royuela Vicente, Phd
Organizational Affiliation
Hospital Universitario Puerta de Hierro Majadahonda
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Cristina Ruiz González, PT
Organizational Affiliation
Hospital Universitario Puerta de Hierro Majadahonda
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Silvia Herguedas Cristobal, PT
Organizational Affiliation
Hospital Universitario Puerta de Hierro Majadahonda
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Sofia González López, MD
Organizational Affiliation
Hospital Universitario Puerta de Hierro Majadahonda
Official's Role
Study Chair
Facility Information:
Facility Name
Laura Muelas Gómez
City
Majadahonda
State/Province
Madrid
ZIP/Postal Code
28222
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Laura Muelas Gómez, PT, MSc
Phone
+0034 656605303
Email
laura.muelas@salud.madrid.org
First Name & Middle Initial & Last Name & Degree
Montserrat Solis Muñoz, DUE, PhD
Phone
+0034 911917457
Email
montserrat.solis@salud.madrid.org

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
For now I don't want to share information about the study until I have the protocol or some published results of the intervention. At that time, the information will be shared with the other researchers.
Citations:
PubMed Identifier
29843525
Citation
Pehlivan E, Mutluay F, Balci A, Kilic L. The effects of inspiratory muscle training on exercise capacity, dyspnea and respiratory functions in lung transplantation candidates: a randomized controlled trial. Clin Rehabil. 2018 Oct;32(10):1328-1339. doi: 10.1177/0269215518777560. Epub 2018 May 30.
Results Reference
background
Citation
Nissan Graur PW and MRK. Annals of Physiotherapy Clinics Effects of Inspiratory Muscle Training on Respiratory Muscle Strength , Functional Capacity and Health Related Quality of Life of Patients Following Lung Transplantation. Ann Physiother Clin. 2020;2(1):10-2.
Results Reference
background
Citation
Neumannova K, Kuzilkova V, Zurková M, Hubackova L, Michalcikova T, Jakubec P, et al. Respiratory muscle training improves the work of breathing and decreases inspiratory muscle fatigue in patients after lung transplantation. Eur Respir J. 2019 Sep 28;54(suppl 63)
Results Reference
background
PubMed Identifier
21282809
Citation
Gosselink R, De Vos J, van den Heuvel SP, Segers J, Decramer M, Kwakkel G. Impact of inspiratory muscle training in patients with COPD: what is the evidence? Eur Respir J. 2011 Feb;37(2):416-25. doi: 10.1183/09031936.00031810.
Results Reference
background
PubMed Identifier
31429627
Citation
Hoffman M, Augusto VM, Eduardo DS, Silveira BMF, Lemos MD, Parreira VF. Inspiratory muscle training reduces dyspnea during activities of daily living and improves inspiratory muscle function and quality of life in patients with advanced lung disease. Physiother Theory Pract. 2021 Aug;37(8):895-905. doi: 10.1080/09593985.2019.1656314. Epub 2019 Aug 20.
Results Reference
background
PubMed Identifier
28093920
Citation
Kendall F, Oliveira J, Peleteiro B, Pinho P, Bastos PT. Inspiratory muscle training is effective to reduce postoperative pulmonary complications and length of hospital stay: a systematic review and meta-analysis. Disabil Rehabil. 2018 Apr;40(8):864-882. doi: 10.1080/09638288.2016.1277396. Epub 2017 Jan 17.
Results Reference
background
PubMed Identifier
22390625
Citation
Langer D, Burtin C, Schepers L, Ivanova A, Verleden G, Decramer M, Troosters T, Gosselink R. Exercise training after lung transplantation improves participation in daily activity: a randomized controlled trial. Am J Transplant. 2012 Jun;12(6):1584-92. doi: 10.1111/j.1600-6143.2012.04000.x. Epub 2012 Mar 5.
Results Reference
background
PubMed Identifier
31241521
Citation
Candemir I, Ergun P, Kaymaz D, Demir N, Tasdemir F, Sengul F, Egesel N, Yekeler E. The Efficacy of Outpatient Pulmonary Rehabilitation After Bilateral Lung Transplantation. J Cardiopulm Rehabil Prev. 2019 Jul;39(4):E7-E12. doi: 10.1097/HCR.0000000000000391.
Results Reference
background
PubMed Identifier
34290002
Citation
Yamaga T, Yamamoto S, Sakai Y, Ichiyama T. Effects of inspiratory muscle training after lung transplantation in children. BMJ Case Rep. 2021 Jul 21;14(7):e241114. doi: 10.1136/bcr-2020-241114.
Results Reference
background
PubMed Identifier
19481017
Citation
Langer D, Gosselink R, Pitta F, Burtin C, Verleden G, Dupont L, Decramer M, Troosters T. Physical activity in daily life 1 year after lung transplantation. J Heart Lung Transplant. 2009 Jun;28(6):572-8. doi: 10.1016/j.healun.2009.03.007. Epub 2009 May 5.
Results Reference
background

Learn more about this trial

Efficacy of Early Inspiratory Muscle Training in Lung Transplanted Patients

We'll reach out to this number within 24 hrs